Codes ATC:
J01XX08
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis
Code ICD11:
ML32.00
INN
Linezolid
Type de médicament
Chemical agent
Groupes d'antibiotiques
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Additional notes
Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB contol.
Formulations
Oral > Solid > dispersible tablet:
150 mg (scored)
(EMLc)
Oral > Solid > tablet: 600 mg
Oral > Solid > tablet: 600 mg
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Main patents have expired but secondary patents might remain active in some jurisdictions. For more
information on specific patents and license status for developing countries visit www.MedsPal.org
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
The Expert Committee recommended the transfer of listings for medicines for multi-drug resistant tuberculosis from the complementary to the core list of the EML and EMLc.
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- to modify the formulation descriptions to better describe the available dosage forms.